市場調查報告書
商品編碼
980783

穿著型自動心臟去顫器 (WCD)的全球市場:∼2028年

Global Wearable Cardioverter Defibrillator Market Outlook 2028

出版日期: | 出版商: Research Nester | 英文 553 Pages | 商品交期: 最快1-2個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

穿著型自動心臟去顫器 (WCD)的市場規模在預測期間內預計以25.45%的年複合成長率發展,2028年約成長到11億美元的規模。政府和世界衛生組織等組織對提供資金的各種國際醫療保健計劃的投資增加,老年人口增加,疾病盛行率、發病率的變化,服務的成本增加等要素預計促進該市場的成長。

本報告提供全球穿著型自動心臟去顫器 (WCD)的市場調查,市場定義和概要,新型冠狀病毒感染疾病 (COVID-19) 以及其他的市場影響因素分析,相關法律、標準、規格,疫情趨勢,市場規模的變化、預測,適應症、人口層、終端用戶、地區/主要國家等各種區分的明細,競爭環境,主要企業簡介等資訊彙整。

第1章 簡介

  • 市場定義
  • 市場分類
  • 產品概要

第2章 假設、縮寫

第3章 調查手法

第4章 分析師的檢討

第5章 摘要整理

第6章 法規、標準

第7章 市場動態

  • 成長要素
  • 市場趨勢

第8章 市場成長的主要障礙

第9章 風險分析

第10章 COVID-19的影響

第11章 主要市場機會

第12章 流行病學分析

第13章 製造商分析

第14章 終端用戶分析

第15章 事業開發的成長機會分析

第16章 生態系統分析

第17章 競爭結構

  • Zoll Medical Corporation
  • Kestra Medical Technologies, Inc.
  • Element Science
  • Medtronic
  • General Electric

第18章 市場預測

  • 市場規模、預測
  • 各適應症
    • 周產期心肌病
    • 先天性心臟病
    • 心室心律不整
    • 法洛氏四合症
    • 心肌梗塞
    • WPW症候群
    • 其他
  • 各人口層
    • 兒童
    • 成人
    • 老年人
  • 各終端用戶
    • 醫院
    • 居家照護
    • 循環系統診所
  • 各地區
    • 亞太地區
    • 北美
    • 南美
    • 歐洲
    • 中東、非洲

第19章 北美市場預測:各主要國家

第20章 歐洲市場預測:各主要國家

第21章 亞太地區市場預測:各主要國家

第22章 南美市場預測:各主要國家

第23章 中東、非洲市場預測:各主要國家

目錄

Global Wearable Cardioverter Defibrillators Market Analysis 2019-2028

Wearable cardioverter defibrillators are wearable devices which are capable of administering electrical shock to the heart for preventing sudden cardiac death (SDC). The major cause of death is cardiovascular disorder, as a result of which, a significant number of new manufacturers are interested to invest in new technologies for providing advanced screening and treatment options. An external defibrillator is attached in the wearable cardioverter defibrillator to a vest that is worn by the patient. It is highly used in patients to bridge the situation where the patient is looking for an Implantable Cardioverter Defibrillator (ICD). The value of global wearable cardioverter defibrillator market is expected to reach around USD 1100 million by 2028, by registering a CAGR of 25.45% across the globe during the forecast period, i.e. 2021-2028. The increasing investment in various international healthcare programs funded by the government and other organizations such as the World Health Organization, increasing old age population, changes in disease prevalence or incidence rate, and increasing cost of services, are the major factors accelerating the market growth.

The global wearable cardioverter defibrillator market consists of various segments that are segmented by indication, demography, end user, and by region. The market is further segmented by demography into pediatric, adults, and geriatric. Out of these, the adult segment recorded the highest share, as the adult population in the world has increased rapidly over the past few years. People with high-risk of cardiovascular diseases usually include adults with hypertension, diabetes, obesity, and other factors. Adults segment is estimated to touch around USD 150,000 thousand in 2020. Moreover, the increasing geriatric population across the world is expected to raise demand for wearable cardioverter defibrillator to monitor and manage cardiovascular diseases. Among pediatric patients, congenital heart disease is the most common heart defect. Although cardiovascular disorders are a great concern in adult population, the increasing prevalence of childhood obesity has increased the risk of cardiovascular complications in children, which in turn is anticipated to drive the growth of the wearable cardioverter defibrillators market.

Based on region, the global wearable cardioverter defibrillators market is segmented into five major regions including North America, Latin America, Europe, Asia Pacific, Middle East and Africa. Among these regions, the market in North America had registered the largest share of around 47% in the year 2019 and is expected to grow significantly over the years on the back of increasing investment towards the medical device sector from government and private organizations to maintain the highest quality of services. Owing to various innovations in devices and tools used, there has been a rise in demand for efficient resources across the medical devices sector. Moreover, the Europe wearable cardioverter defibrillators market is expected to reach a market size of around USD 320,000 thousand by 2028 owing to the increasing demand for advanced medical devices owing to the changing medical practices and the rise of new manufacturing technologies.

Some of the prominent industry leaders in the global wearable cardioverter defibrillators market are: ZOLL Medical Corporation, Element Science Inc., Medtronic plc, Kestra Medical Technologies Inc., Abbott, Boston Scientific Corporation, LivaNova plc, Koninklijke Philips N.V., Nihon Kohden Corporation, and General Electric Company.

TABLE OF CONTENTS

Wearable Cardioverter Defibrillator Market

1. Introduction

  • 1.1. Market Definition
  • 1.2. Market Segmentation
  • 1.3. Product Overview

2. Assumptions And Acronyms

3. Research Methodology

4. Analyst Review

5. Executive Summary - Global Wearable Cardioverter Defibrillator Market

6. Regulatory & Standards Landscape

7. Analysis Of Market Dynamics

  • 7.1. Growth Drivers
  • 7.2. Market Trends

8. Major Roadblocks For The Market Growth

9. Risk Analysis

10. Impact Of Covid-19 On The Wearable Cardioverter Defibrillator Market

11. Key Market Opportunities

12. Epidemiology Analysis

13. Analysis Of Wearable Cardioverter Defibrillator Manufacturers

14. Assessment Of End Users Of Wearable Cardioverter Defibrillator

15. Growth Opportunity Analysis For Business Development

16. Analysis On The Wearable Cardioverter Defibrillator Ecosystem

17. Competitive Structure

O Competitive Benchmarking

O Detailed Overview

O Assessment Of Key Product Offerings

O Analysis Of Growth Strategies

O Exhaustive Analysis On Key Financial Indicators

O Swot Analysis

O Market Share Analysis Of Leading Companies In Wearable Cardioverter Defibrillator Market

O Company Assessment For Players Operating In The Market

> Zoll Medical Corporation

O Company Assessment For Players With Product In Pipeline

> Kestra Medical Technologies, Inc.

> Element Science

> Medtronic

> General Electric

18. Global Wearable Cardioverter Defibrillator Market Outlook

> By Value (USD Million)

Global Wearable Cardioverter Defibrillator Market Segmentation Analysis, 2019-2028

> By Indication

Peripartum Cardiomyopathy, 2019-2028f (USD Thousand)

Congenital Heart Disease, 2019-2028f (USD Thousand)

Ventricular Arrhythmias, 2019-2028f (USD Thousand)

Tetralogy Or Fallot, 2019-2028f (USD Thousand)

Myocardial Infarction, 2019-2028f (USD Thousand)

Wolff-Parkinson White Syndrome, 2019-2028f (USD Thousand)

Others, 2019-2028f (USD Thousand)

> By Demography

Pediatric, 2019-2028f (USD Thousand)

Adults, 2019-2028f (USD Thousand)

Geriatric, 2019-2028f (USD Thousand)

> By End User

Hospitals, 2019-2028f (USD Thousand)

Home Care Settings, 2019-2028f (USD Thousand)

Cardiology Clinics, 2019-2028f (USD Thousand)

> By Region

Asia Pacific, 2019-2028f (USD Thousand)

North America, 2019-2028f (USD Thousand)

Latin America, 2019-2028f (USD Thousand)

Europe, 2019-2028f (USD Thousand)

Middle East & Africa, 2019-2028f (USD Thousand)

19. North America Wearable Cardioverter Defibrillator Market Outlook, 2019-2028

  • 19.1. Market Overview
  • 19.2. Market Size, 2019-2028f (USD Thousand)
  • 19.3. Assessment Of Macroeconomic Factors
  • 19.4. Analysis Of Leading Companies
  • 19.5. Market Segmentation

> By Indication

> By Demography

> By End User

> By Country

US, 2019-2028f (USD Thousand)

Canada, 2019-2028f (USD Thousand)

20. Europe Wearable Cardioverter Defibrillator Market Outlook, 2019-2028

  • 20.1. Market Overview
  • 20.2. Market Size, 2019-2028f (USD Thousand)
  • 20.3. Assessment Of Macroeconomic Factors
  • 20.4. Analysis Of Leading Companies
  • 20.5. Market Segmentation

> By Indication

> By Demography

> By End User

> By Country

Germany, 2019-2028f (USD Thousand)

UK, 2019-2028f (USD Thousand)

France, 2019-2028f (USD Thousand)

Italy, 2019-2028f (USD Thousand)

Spain, 2019-2028f (USD Thousand)

Russia, 2019-2028f (USD Thousand)

Rest Of Europe, 2019-2028f (USD Thousand)

21. Asia Pacific Wearable Cardioverter Defibrillator Market Outlook, 2019-2028

  • 21.1. Market Overview
  • 21.2. Market Size, 2019-2028f (USD Thousand)
  • 21.3. Market Segmentation

> By Indication

> By Demography

> By End User

> By Country

China, 2019-2028f (USD Thousand)

India, 2019-2028f (USD Thousand)

Japan, 2019-2028f (USD Thousand)

South Korea, 2019-2028f (USD Thousand)

Australia, 2019-2028f (USD Thousand)

Malaysia, 2019-2028f (USD Thousand)

Singapore, 2019-2028f (USD Thousand)

Vietnam, 2019-2028f (USD Thousand)

Rest Of Asia Pacific, 2019-2028f (USD Thousand)

22. Latin America Wearable Cardioverter Defibrillator Market Outlook, 2019-2028

  • 22.1. Market Overview
  • 22.2. Market Size, 2019-2028f (USD Thousand)
  • 22.3. Assessment Of Macroeconomic Factors
  • 22.4. Analysis Of Leading Companies
  • 22.5. Market Segmentation

> By Indication

> By Demography

> By End User

> By Country

Brazil, 2019-2028f (USD Thousand)

Mexico, 2019-2028f (USD Thousand)

Argentina, 2019-2028f (USD Thousand)

Rest Of Latin America, 2019-2028f (USD Thousand)

23. Middle East & Africa Wearable Cardioverter Defibrillator Market Outlook, 2019-2028

  • 23.1. Market Overview
  • 23.2. Market Size, 2019-2028f (USD Thousand)
  • 23.3. Assessment Of Macroeconomic Factors
  • 23.4. Analysis Of Leading Companies
  • 23.5. Market Segmentation

> By Indication

> By Demography

> By End User

> By Country

GCC, 2019-2028f (USD Thousand)

Israel, 2019-2028f (USD Thousand)

South Africa, 2019-2028f (USD Thousand)

Rest Of Middle Eat & Africa, 2019-2028f (USD Thousand)